Group 1 - The Hong Kong Stock Connect Innovative Drug ETF (159570) experienced a decline of 2.35% with a trading volume of 1.584 billion yuan on December 29 [1] - The ETF's shares increased by 7 million, bringing the total shares to 13.841 billion, with a total increase of 273 million shares over the last 20 trading days [1] - The latest net asset value of the ETF is calculated to be 21.917 billion yuan [1] Group 2 - The performance benchmark for the ETF is the National Index of Hong Kong Stock Connect Innovative Drugs, adjusted for valuation exchange rates [1] - The fund is managed by E Fund Management Co., Ltd., with the fund manager being Le Wuqiong [1] - Since its establishment on December 28, 2023, the ETF has returned 58.35%, while the return over the past month is -10.84% [1]
12月29日港股通创新药ETF（159570）份额增加700.00万份
Xin Lang Cai Jing·2025-12-30 01:10